Article info
Current controversy
Global equitable access to vaccines, medicines and diagnostics for COVID-19: The role of patents as private governance
- Correspondence to Dr Aisling McMahon, Department of Law, National University of Ireland Maynooth, Maynooth, Kildare, Ireland; aisling.mcmahon{at}mu.ie
Citation
Global equitable access to vaccines, medicines and diagnostics for COVID-19: The role of patents as private governance
Publication history
- Received August 12, 2020
- Revised October 12, 2020
- Accepted October 13, 2020
- First published November 30, 2020.
Online issue publication
February 22, 2021
Article Versions
- Previous version (30 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
- Intellectual property waiver for covid-19 vaccines will advance global health equity
- Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- COVID-19 vaccines pricing policy options for low-income and middle- income countries
- The COVID-19 vaccine patent: a right without rationale
- Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
- Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity
- Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers